SAFC’s approach to staying Flexible in a Changing Market – SAFC moves ahead with ADCs
Click HERE to download the PDF version
Pharmaceutical innovation is being redefined across the globe, and regulations for drug products are becoming more stringent every day. As a supplier to drug manufacturers big and small, SAFC, the custom manufacturing services business unit of Sigma-Aldrich, sees these changes as an opportunity to enhance our commitment to customers.
Total global spending on medicines is expected to exceed $1 trillion for the first time in 2014, and reach almost $1.2 trillion in 2017. This growth is diverse, shattering the “traditional” concept of pharmaceutical production. While many factors have contributed to the dynamic pharmaceutical landscape of today and the future, a few notable trends have acted as fundamental drivers of this change:
- A shift in focus from blockbuster drugs to specialist care drugs ... ...